Literature DB >> 17224564

Bosentan as a rescue therapy in scleroderma refractory digital ulcers.

Melanie Chamaillard, Isabelle Heliot-Hosten, Joël Constans, Alain Taïeb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17224564     DOI： 10.1001/archderm.143.1.125

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

1.  [Treatment of a leg ulcer with bosentan in a female patient with progressive systemic scleroderma].

Authors:  I Rösener; A Rübben
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

2.  Digital ulcers in scleroderma patients: A retrospective observational study.

Authors:  A De Cata; M Inglese; F Molinaro; S De Cosmo; R Rubino; M Bernal; G Mazzoccoli
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

3.  Effects of bosentan on the skin lesions: an observational study from a single center in Japan.

Authors:  Masanori Funauchi; K Kishimoto; H Shimazu; Y Nagare; S Hino; T Yano; K Kinoshita
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

4.  Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis.

Authors:  Kait Arefiev; David F Fiorentino; Lorinda Chung
Journal:  Int J Rheumatol       Date:  2011-10-27

5.  Swift and Complete Healing of Digital Ulcers after Macitentan Treatment.

Authors:  Emilio Giner Serret
Journal:  Case Rep Rheumatol       Date:  2016-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.